Molecular profiling as a predictor of treatment response and survival in unresectable pancreatic ductal adenocarcinoma

被引:0
|
作者
Paredes, Rodrigo [1 ]
Banegas, Marcela [1 ]
Sucre, Santiago [1 ]
Ponce, Cristina [1 ]
Rattani, Ahmed Anwer Ali [1 ]
Peters, Mary Linton Bounetheau [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16279
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel
    de la Fuente, Rodrigo Paredes
    Sucre, Santiago
    Ponce, Cristina
    Rattani, Ahmed Anwer Ali
    Peters, Mary Linton B.
    CANCERS, 2024, 16 (15)
  • [2] Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma
    Lee, Jaewon James
    Yeh, Jen Jen
    SURGICAL CLINICS OF NORTH AMERICA, 2024, 104 (05) : 939 - 950
  • [3] SMAD4 Loss is a Predictor of Neoadjuvant Treatment Response in Pancreatic Ductal Adenocarcinoma
    Ramanathan, R.
    Hodges, J.
    Al-Abbas, A.
    Buchholz, C.
    Singhi, A.
    Zeh, H.
    Hogg, M. E.
    Zureikat, A. H.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S34 - S34
  • [4] Keratin 17 as a predictor of chemotherapy response in pancreatic ductal adenocarcinoma
    Oblein, Lyanne
    Roa, Lucia
    Babu, Sruthi
    Horowitz, Michael
    Petricoin, Emanuel
    Matrisian, Lynn M.
    Blais, Edik
    Marchenko, Natalia
    Allard, Felicia
    Alkalin, Ali
    Jiang, Wei
    Larson, Brent
    Hendifar, Andrew
    Picozzi, Vincent
    Choi, Minsig
    Escobar-Hoyos, Luisa
    Shroyer, Kenneth
    CANCER RESEARCH, 2024, 84 (02)
  • [5] Comprehensive molecular profiling of pancreatic ductal adenocarcinoma in Chinese population
    Liu, R.
    Li, X.
    Liu, Q.
    Zhao, Z.
    Yuan, H.
    Ma, T.
    ANNALS OF ONCOLOGY, 2020, 31 : S945 - S945
  • [6] Evolving Treatment Options for Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
    Cinar, Pelin
    Ko, Andrew H.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (02): : 167 - 172
  • [7] The Impact of Pathologic Complete Response on Survival in Pancreatic Ductal Adenocarcinoma
    Sell, N. M.
    Lee, G. C.
    Ferrone, C. R.
    del Castillo, C. Fernandez
    Warshaw, A. L.
    Blaszkowsky, L. S.
    Lillemoe, K. D.
    Qadan, M.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S134 - S135
  • [8] Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments
    Bugazia, Doaa
    Al-Najjar, Ebtesam
    Esmail, Abdullah
    Abdelrahim, Saifudeen
    Abboud, Karen
    Abdelrahim, Adham
    Umoru, Godsfavour
    Rayyan, Hashem A.
    Abudayyeh, Ala
    Al Moustafa, Ala-Eddin
    Abdelrahim, Maen
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [9] Microscopic Lymphovascular Invasion is an Independent Predictor of Survival in Resected Pancreatic Ductal Adenocarcinoma
    Epstein, J.
    Kozak, G.
    Fong, Z.
    He, J.
    Javed, A.
    Joneja, U.
    Jiang, W.
    Ferrone, C.
    Lillemoe, K. D.
    Cameron, J.
    Weiss, M.
    Lavu, H.
    Yeo, C. J.
    Fernandez-del Castillo, C.
    Wolfgang, C.
    Winter, J.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S14 - S14
  • [10] Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma
    Epstein, Jeffrey D.
    Kozak, Geoffrey
    Fong, Zhi Ven
    He, Jin
    Javed, Ammar A.
    Joneja, Upasana
    Jiang, Wei
    Ferrone, Cristina R.
    Lillemoe, Keith D.
    Cameron, John L.
    Weiss, Matthew J.
    Lavu, Harish
    Yeo, Charles J.
    Fernandez-del Castillo, Carlos
    Wolfgang, Christopher L.
    Winter, Jordan M.
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (06) : 658 - 664